委员会条例(EU) No 213/2011，修订关于专业资格认证的欧洲议会和理事会指令2005/36/EC 的附录II和V
技术法规类型：欧盟Eurlex法规 来源：tbtmap
EURLEX ID：32011R0213
OJ编号：OJ L 59, 4.3.2011, p. 4-7
中文标题：委员会条例(EU) No 213/2011，修订关于专业资格认证的欧洲议会和理事会指令2005/36/EC 的附录II和V
原文标题：Commission Regulation (EU) No 213/2011 of 3 March 2011 amending Annexes II and V to Directive 2005/36/EC of the European Parliament and of the Council on the recognition of professional qualifications (1)
分类：06.20.50_医药活动
文件类型：二级立法 Regulation|条例
生效日期：2011-03-24
废止日期：2058-12-31
法规全文：查看欧盟官方文件
HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"
EN
Official Journal of the European Union
4.3.2011
COMMISSION REGULATION (EU) No 213/2011
of 3 March 2011
amending Annexes II and V to Directive 2005/36/EC of the European Parliament and of the Council
on the recognition of professional qualifications
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
training in more than two fifths of the Member States,
which justifies its inclusion into point 5.1.3 of Annex V
to Directive 2005/36/EC.
Having regard to the Treaty on the Functioning of the European
Union,
(5)
In order to ensure a sufficiently high level of specialist
medical training, the minimum period of training
required for the medical specialty of medical oncology
Having regard to Directive 2005/36/EC of the European
to be automatically recognised should be five years.
Parliament and of the Council of 7 September 2005 on the
recognition of professional qualifications ( 1 ), and in particular
the second paragraph of Article 11 and the second paragraph
(6) France
has
submitted
a
reasoned
request
to
include
in
of Article 26,
point 5.1.3 of Annex V to Directive 2005/36/EC
specialist medical training in medical genetics.
Whereas:
(7)
Medical genetics is a specialty that responds to the rapid
development of knowledge in the field of genetics and its
implication in numerous specialised fields, such as
(1) Austria
has
requested
the
insertion
in
Annex
II
to
oncology, foetal medicine, paediatrics, chronic diseases.
Directive 2005/36/EC of 10 training programmes
Medical genetics plays a growing role in screening and
related to healthcare. These training programmes are
in the prevention of numerous pathologies. Specialist
regulated by the Healthcare and Nursing Special Task
medical training in medical genetics is not listed in
Ordinance (GuK-SV BGBl II No 452/2005) and the
point 5.1.3 of Annex V to Directive 2005/36/EC.
Healthcare and Nursing Teaching and Management
However, it has developed into a separate and distinct
Duties Ordinance (GuK-LFV BGBl II No 453/2005).
specialist medical training in more than two fifths of the
Member States, which justifies its inclusion into point
5.1.3 of Annex V to Directive 2005/36/EC.
(2) As
these
Austrian
training
programmes
are
of
an
equivalent level of training to that provided for under
Article 11(c)(i) of Directive 2005/36/EC and provide a
(8)
In order to ensure a sufficiently high level of specialist
comparable professional standard and prepare the
medical training, the minimum period of training
trainee for a comparable level of responsibilities and
required for the medical specialty of medical genetics
functions, their inclusion on the basis of
to be automatically recognised should be four years.
Article 11(c)(ii) in Annex II to Directive 2005/36/EC is
justified.
(9) Directive
2005/36/EC
should
therefore
be
amended
accordingly.
(3) Portugal
has
submitted
a
reasoned
request
to
include
in
point 5.1.3 of Annex V to Directive 2005/36/EC
specialist medical training in medical oncology.
(10) The
measures
provided
for
in
this
Regulation
are
in
accordance with the opinion of the Committee on the
Recognition of Professional Qualifications,
(4) Medical
oncology
aims
at
offering
a
systemic
treatment
of cancer. The treatment of cancer patients has
undergone major changes over the last decade due to
HAS ADOPTED THIS REGULATION:
scientific progress. Specialist medical training in medical
oncology is not listed in point 5.1.3 of Annex V to
Directive 2005/36/EC. However, medical oncology has
developed into a separate and distinct specialist medical
Article 1
Annexes II and V to Directive 2005/36/EC are amended as set
( 1 ) OJ L 255, 30.9.2005, p. 22.
out in the Annex to this Regulation.
EN
4.3.2011 Official
Journal
of
the
European
Union L
59/5
Article 2
This Regulation shall enter into force on the 20th day following its publication in the Official Journal of the
European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 3 March 2011.
For the Commission
The President
José Manuel BARROSO
L 59/6
EN
Official Journal of the European Union
4.3.2011
ANNEX
Annexes II and V to Directive 2005/36/EC are amended as follows:
1. in point 1 of Annex II, under ‘in Austria’, the following is added:
‘— special training in the care of children and young people (Sonderausbildung in der Kinder- und Jugendlichenpflege),
— special training in psychiatric healthcare and nursing (Sonderausbildung in der psychiatrischen Gesundheits- und
Krankenpflege),
— special training in intensive care (Sonderausbildung in der Intensivpflege),
— special training in intensive care of children (Sonderausbildung in der Kinderintensivpflege),
— special training in anaesthesia-related nursing (Sonderausbildung in der Ansthesiepflege),
— special training in renal replacement therapy related nursing (Sonderausbildung in der Pflege bei Nierenersatz
therapie),
— special training in operating department nursing (Sonderausbildung in der Pflege im Operationsbereich),
— special training in hospital hygiene (Sonderausbildung in der Krankenhaushygiene),
— special training for teaching tasks in healthcare and nursing (Sonderausbildung für Lehraufgaben in der
Gesundheits- und Krankenpflege),
— special training for management tasks in healthcare and nursing. (Sonderausbildung für Führungsaufgaben in der
Gesundheits- und Krankenpflege),
which represents education and training courses of a total duration of at least 13 years and six months to 14 years,
including at least 10 years’ general education, a further three years’ basic training in the upper-grade public service for
healthcare and nursing, and six to 12 months’ special training in a specialised, teaching or management task.’;
2. the following table is added to point 5.1.3 of Annex V:
Medical oncology
Medical genetics
Minimum period of training:
Minimum period of training:
‘Country
5 years
4 years
Title Title
Belgique/Belgi/Belgien Oncologie
médicale/
Medische
oncologie
България
Медицинска онкология
Медицинска генетика
eská republika Klinická
onkologie Lékaská genetika
Danmark Klinisk
genetik
Deutschland Humangenetik
Eesti Meditsiinigeneetika
Ελλ
Παθολογικ Ογκολογα
Espaa
France Oncologie Génétique
médicale
Ireland Medical
oncology Clinical
genetics
Italia Oncologia
medica Genetica
medica
Κπρο
Ακτινοθεραπευτικ Ογκολογα
Latvija Onkoloija īmijterapija Medicīnas enētika
EN
4.3.2011 Official
Journal
of
the
European
Union L
59/7
Medical oncology
Medical genetics
Minimum period of training:
Minimum period of training:
Country
5 years
4 years
Title Title
Lietuva Chemoterapin onkologija Genetika
Luxembourg Oncologie
médicale Médecine
génétique
Magyarország Klinikai
onkológia Klinikai
genetika
Malta
Nederland Klinische
genetica
sterreich Medizinische
Genetik
Polska Onkologia
kliniczna Genetyka
kliniczna
Portugal Oncologia
médica Genética
médica
Romnia Oncologie
medicala Genetica
medicala
Slovenija Internistina onkologija Klinina genetika
Slovensko Klinická
onkológia Lekárska
genetica
Suomi/Finland Perinnllisyyslketiede/
Medicinsk genetik
Sverige
United Kingdom Medical
oncology Clinical
genetics’
EN
Official Journal of the European Union
4.3.2011
COMMISSION REGULATION (EU) No 213/2011
of 3 March 2011
amending Annexes II and V to Directive 2005/36/EC of the European Parliament and of the Council
on the recognition of professional qualifications
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
training in more than two fifths of the Member States,
which justifies its inclusion into point 5.1.3 of Annex V
to Directive 2005/36/EC.
Having regard to the Treaty on the Functioning of the European
Union,
(5)
In order to ensure a sufficiently high level of specialist
medical training, the minimum period of training
required for the medical specialty of medical oncology
Having regard to Directive 2005/36/EC of the European
to be automatically recognised should be five years.
Parliament and of the Council of 7 September 2005 on the
recognition of professional qualifications ( 1 ), and in particular
the second paragraph of Article 11 and the second paragraph
(6) France
has
submitted
a
reasoned
request
to
include
in
of Article 26,
point 5.1.3 of Annex V to Directive 2005/36/EC
specialist medical training in medical genetics.
Whereas:
(7)
Medical genetics is a specialty that responds to the rapid
development of knowledge in the field of genetics and its
implication in numerous specialised fields, such as
(1) Austria
has
requested
the
insertion
in
Annex
II
to
oncology, foetal medicine, paediatrics, chronic diseases.
Directive 2005/36/EC of 10 training programmes
Medical genetics plays a growing role in screening and
related to healthcare. These training programmes are
in the prevention of numerous pathologies. Specialist
regulated by the Healthcare and Nursing Special Task
medical training in medical genetics is not listed in
Ordinance (GuK-SV BGBl II No 452/2005) and the
point 5.1.3 of Annex V to Directive 2005/36/EC.
Healthcare and Nursing Teaching and Management
However, it has developed into a separate and distinct
Duties Ordinance (GuK-LFV BGBl II No 453/2005).
specialist medical training in more than two fifths of the
Member States, which justifies its inclusion into point
5.1.3 of Annex V to Directive 2005/36/EC.
(2) As
these
Austrian
training
programmes
are
of
an
equivalent level of training to that provided for under
Article 11(c)(i) of Directive 2005/36/EC and provide a
(8)
In order to ensure a sufficiently high level of specialist
comparable professional standard and prepare the
medical training, the minimum period of training
trainee for a comparable level of responsibilities and
required for the medical specialty of medical genetics
functions, their inclusion on the basis of
to be automatically recognised should be four years.
Article 11(c)(ii) in Annex II to Directive 2005/36/EC is
justified.
(9) Directive
2005/36/EC
should
therefore
be
amended
accordingly.
(3) Portugal
has
submitted
a
reasoned
request
to
include
in
point 5.1.3 of Annex V to Directive 2005/36/EC
specialist medical training in medical oncology.
(10) The
measures
provided
for
in
this
Regulation
are
in
accordance with the opinion of the Committee on the
Recognition of Professional Qualifications,
(4) Medical
oncology
aims
at
offering
a
systemic
treatment
of cancer. The treatment of cancer patients has
undergone major changes over the last decade due to
HAS ADOPTED THIS REGULATION:
scientific progress. Specialist medical training in medical
oncology is not listed in point 5.1.3 of Annex V to
Directive 2005/36/EC. However, medical oncology has
developed into a separate and distinct specialist medical
Article 1
Annexes II and V to Directive 2005/36/EC are amended as set
( 1 ) OJ L 255, 30.9.2005, p. 22.
out in the Annex to this Regulation.
EN
4.3.2011 Official
Journal
of
the
European
Union L
59/5
Article 2
This Regulation shall enter into force on the 20th day following its publication in the Official Journal of the
European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 3 March 2011.
For the Commission
The President
José Manuel BARROSO
L 59/6
EN
Official Journal of the European Union
4.3.2011
ANNEX
Annexes II and V to Directive 2005/36/EC are amended as follows:
1. in point 1 of Annex II, under ‘in Austria’, the following is added:
‘— special training in the care of children and young people (Sonderausbildung in der Kinder- und Jugendlichenpflege),
— special training in psychiatric healthcare and nursing (Sonderausbildung in der psychiatrischen Gesundheits- und
Krankenpflege),
— special training in intensive care (Sonderausbildung in der Intensivpflege),
— special training in intensive care of children (Sonderausbildung in der Kinderintensivpflege),
— special training in anaesthesia-related nursing (Sonderausbildung in der Ansthesiepflege),
— special training in renal replacement therapy related nursing (Sonderausbildung in der Pflege bei Nierenersatz
therapie),
— special training in operating department nursing (Sonderausbildung in der Pflege im Operationsbereich),
— special training in hospital hygiene (Sonderausbildung in der Krankenhaushygiene),
— special training for teaching tasks in healthcare and nursing (Sonderausbildung für Lehraufgaben in der
Gesundheits- und Krankenpflege),
— special training for management tasks in healthcare and nursing. (Sonderausbildung für Führungsaufgaben in der
Gesundheits- und Krankenpflege),
which represents education and training courses of a total duration of at least 13 years and six months to 14 years,
including at least 10 years’ general education, a further three years’ basic training in the upper-grade public service for
healthcare and nursing, and six to 12 months’ special training in a specialised, teaching or management task.’;
2. the following table is added to point 5.1.3 of Annex V:
Medical oncology
Medical genetics
Minimum period of training:
Minimum period of training:
‘Country
5 years
4 years
Title Title
Belgique/Belgi/Belgien Oncologie
médicale/
Medische
oncologie
България
Медицинска онкология
Медицинска генетика
eská republika Klinická
onkologie Lékaská genetika
Danmark Klinisk
genetik
Deutschland Humangenetik
Eesti Meditsiinigeneetika
Ελλ
Παθολογικ Ογκολογα
Espaa
France Oncologie Génétique
médicale
Ireland Medical
oncology Clinical
genetics
Italia Oncologia
medica Genetica
medica
Κπρο
Ακτινοθεραπευτικ Ογκολογα
Latvija Onkoloija īmijterapija Medicīnas enētika
EN
4.3.2011 Official
Journal
of
the
European
Union L
59/7
Medical oncology
Medical genetics
Minimum period of training:
Minimum period of training:
Country
5 years
4 years
Title Title
Lietuva Chemoterapin onkologija Genetika
Luxembourg Oncologie
médicale Médecine
génétique
Magyarország Klinikai
onkológia Klinikai
genetika
Malta
Nederland Klinische
genetica
sterreich Medizinische
Genetik
Polska Onkologia
kliniczna Genetyka
kliniczna
Portugal Oncologia
médica Genética
médica
Romnia Oncologie
medicala Genetica
medicala
Slovenija Internistina onkologija Klinina genetika
Slovensko Klinická
onkológia Lekárska
genetica
Suomi/Finland Perinnllisyyslketiede/
Medicinsk genetik
Sverige
United Kingdom Medical
oncology Clinical
genetics’
附件:
托管标准，您可以接收以下服务：
1 标准定期系统查新,若有最新版本,会以站内短信或邮件的形式通知用户；
2 随时在标准托管页面中查看到该条标准的最新状态；
3 若用户有在学习和科研中的需要，可以在标准托管页面中试阅标准；
4 企业如果需要上新产品,我院及时提供标准查询、采购等方面的支持；
5 为企业在标准制修订、企业良好行为创建以及标准化试点过程中遇到的困难,可联系我院指定相关专家负责进行指导帮助、提供政策咨询；
6 为企业提供标准化政策的解读、标准化知识的推广培训、标准自我公开声明、标准文献的免费查询、企业标准化体系建设等方面的标准化服务；
标准资讯点击排行榜 全部
资讯标题点击
[[ n.title ]] [[ n.read ]]大连标准化公共服务平台
版权：大连标准化研究院有限公司
地址：大连市中山区高原街56号
电话：0411-82740851
